Monday, 15 October 2018

Docturnal receives investment from Mumbai Angels Network

26 September 2018 | News

The Hyderabad-based startup will use the capital to deploy its product for clinical trials across several hospitals.

Docturnal Pvt. Ltd, a healthcare startup focused on non-invasive screening solutions for tuberculosis, has recently raised an undisclosed sum from Mumbai Angels Network.

11 investors from the network have invested in the company. The investors include Akshay Mittal, founder of basmati rice maker Sagar Basmati Rice; angel investor Abhijeet Birewar; and Shantanu Agarwal, executive director at automotive furnishing fabric manufacturer BMD Pvt. Ltd, to name a few.

Docturnal screens and detects tuberculosis using their flagship product TimBre. The product can also be used to screen other lung-based ailments such as asthma, chronic obstructive pulmonary disease (COPD) and others that have a cough as a symptomatic condition.

The Hyderabad-based startup will use the capital to deploy the product for clinical trials across several hospitals in the country and also to build its team and technology.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Click Here!




Survey Box

Can blockchain help cease fake drug distribution in India?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls